Evidence map›Paper›PMID 35292622›Full record

ArticleBlood cancer journal2022

Increased mortality risk in multiple-myeloma patients with subsequent malignancies: a population-based study in the Netherlands.

Mirian Brink, Monique C Minnema, Otto Visser, Mark-David Levin, Eduardus F M Ward Posthuma, Annemiek Broijl, Pieter Sonneveld, Marjolein van der Klift, Wilfried W H Roeloffzen, Matthijs Westerman and 5 more

Abstract readLetter
In one paragraph

Article in Blood cancer journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Mirian BrinkDepartment of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands. m.brink@iknl.nl.ORCID 0000-0002-6014-4810
Monique C MinnemaDepartment of Hematology, Cancer Center, UMC Utrecht, Utrecht, The Netherlands.ORCID 0000-0002-3139-8379
Otto VisserDepartment of Registration, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
Mark-David LevinDepartment of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands.ORCID 0000-0003-2139-3547
Eduardus F M Ward PosthumaDepartment of Internal Medicine, Reinier de Graaf Group, Delft, The Netherlands.
Annemiek BroijlDepartment of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Pieter SonneveldDepartment of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.ORCID 0000-0002-0808-2237
Marjolein van der KliftDepartment of Internal Medicine, Amphia Hospital, Breda, The Netherlands.
Wilfried W H RoeloffzenDepartment of Hematology, University Medical Center Groningen, Groningen, The Netherlands.
Matthijs WestermanDepartment of Internal Medicine, Northwest Clinics, Alkmaar, the Netherlands.
Cleo R van RooijenDepartment of Hematology, Medical Center Twente, Enschede, The Netherlands.
Paul A F GeertsDepartment of Hematology, Isala Hospital, Zwolle, The Netherlands.ORCID 0000-0002-1737-7133
Sonja ZweegmanAmsterdam UMC, Vrije Universiteit Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands.
Niels W C J van de DonkAmsterdam UMC, Vrije Universiteit Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands.
Avinash G DinmohamedDepartment of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.ORCID 0000-0002-4767-6716

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Multiple MyelomaNeoplasms, Second PrimaryHumansNetherlands

Identifiers

PMID35292622
PMCPMC8924210

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.